New COVID-19 case in Byron Bay means limited restrictions are back
Queensland recorded three new cases of COVID-19 today (31 March), as residents of Greater Brisbane wait to hear if they will spend the Easter break in lockdown.
From the President: PSA at the FIP World Congress in Seville,...
I have just returned from FIP’s World Congress of Pharmacy and Pharmaceutical Sciences in Seville, where PSA CEO Mark Kinsela, PSA Senior Pharmacist Peter...
First 100,000 Australians receive COVID-19 vaccines
More than 100,000 Australians have received their first COVID-19 vaccination, and the country now has 1.3 million doses on hand for the next rollout phases.
Quick Q&A with Katherine Higgins MPS
Jennifer Cooke, the Editor of Australian Pharmacist, talks with Katherine Higgins, a pharmacist in South Perth, Western Australia.
Antimicrobial use up in disadvantaged areas
Antimicrobial medicines use declined in Australia from 2013 to 2018, but the country’s rate remains high by OECD standards, according to new research.
Efficacy of antiplatelets in deep venous thrombosis
Venous thromboembolism (VTE) is the third most common cardiovascular disease in the world. Every year, 30,000 people in Australia develop VTE, at a cost of $1.72 billion to the Australian health system.
